Benjamin P. Best

Benjamin P. Best

Title: Director of Research Oversight
Company: Biomedical Research and Longevity Society
Location: Fort Lauderdale, Florida, United States

Benjamin P. Best, Director of Research Oversight at Biomedical Research and Longevity Society, has been recognized by Marquis Who’s Who Top Scientists for dedication, achievements, and leadership in biomedical research.

After obtaining a Bachelor of Science in Pharmacy in 1974 from the University of British Columbia in Canada, Mr. Best later followed with a Bachelor of Business Administration in accounting and finance and a Bachelor of Science in physics and computing science in 1987 from Simon Fraser University in British Columbia. From 1987 to 2003, he provided superior service as a senior programmer and analyst with Scotiabank.

Long interested in possible life extension techniques, Mr. Best served as president and chief executive officer of the Cryonics Institute, an American nonprofit foundation that provides cryonics services. The Institute freezes deceased humans and pets in liquid nitrogen with the hope of restoring them with technology in the future. Since 2012, Mr. Best has served as the director of research oversight with the Biomedical Research and Longevity Society, a company whose goals are extending the healthy human lifespan by discovering methods to control aging and eradicate disease. In addition, since 1990 he has directed the Cryonics Society of Canada.

Mr. Best attributes his success to hard work and intelligence. He became involved in his profession due to his desire for a long and healthy life. As a career highlight, he cites publishing an article called “Cryoprotectant Toxicity: Facts, Issues, and Questions” in 2015, which addresses the most important problems involved in microbiology, as well as his work for nine years with the Cryonics Institute. His plan for the coming years is continued research into healthy life extension.

For more information, please visit:

Press Release


Ben Best Website

Contact Mr. Best:

Leave a Reply